ZNF682

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, ZNF682 mutation is significantly associated with the drug of many other genes, with 17 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible ZNF682-associated genes across cancer lineages are AZD1208, CZC24832, and 720427. Each is linked with ZNF682 in more than 1 cancer types. Because this analysis shows association rather than direction, both ZNF682-to-partner and partner-to-ZNF682 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ZNF682→partner) and Y-score (partner→ZNF682) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINEAZD1208 →+0.411+2.649.016.04631
LARGE_INTESTINECZC24832 →+0.275+2.646.034.04731
LARGE_INTESTINE720427 →+0.285+2.649.031.04631
LARGE_INTESTINEJNJ38877605 →+0.368+2.786.034.03731
LARGE_INTESTINE615590 →+0.330+2.649.020.04621
LARGE_INTESTINEMirin →+0.506+2.646.006.04711
Each partner links to its Q-omics profile. Showing the 6 strongest of 17 associations by consensus.

Exploration